During the past decade, Pulmonary and Critical Care Associates of Baltimore conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 10 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pulmonary and Critical Care Associates of Baltimore" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Philips Clinical & Medical Affairs Global" with 2 trials sponsored, "Pulmonary Critical Care Associates of Baltimore" with 2 trials sponsored, "Signifier Medical Technologies" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pulmonary and Critical Care Associates of Baltimore" #1 collaborator was "Pulmonary Critical Care Associates of Baltimore" with 2 trials as a collaborator, "Ajinomoto Co., Inc." with 1 trials as a collaborator, "Gerresheimer" with 1 trials as a collaborator, "HealthCore-NERI" with 1 trials as a collaborator and "PneumRx, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pulmonary and Critical Care Associates of Baltimore" are "Sleep Apnea, Obstructive" (4 trials), "Emphysema" (3 trials), "Asthma" (2 trials), "Lung Diseases, Interstitial" (2 trials) and "Sleep Apnea, Central" (2 trials). Many other conditions were trialed in "Pulmonary and Critical Care Associates of Baltimore" in a lesser frequency.

Most popular intervention types in "Pulmonary and Critical Care Associates of Baltimore" are "Device" (8 trials), "Drug" (8 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Nintedanib" (3 trials), "eXciteOSA" (2 trials), "ADX-N05" (1 trials) and "AZLI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary and Critical Care Associates of Baltimore" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary and Critical Care Associates of Baltimore". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Pulmonary and Critical Care Associates of Baltimore, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary and Critical Care Associates of Baltimore, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".